RapidShock Post-Approval Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2756 participants.

Also called NCT04014842

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,756 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04014842
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04014842. Allocation not applicable; no masking; primary purpose treatment. Start 2019-02-26 (actual); primary completion 2023-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RapidShock Post-Approval Study
Intervention (Device)
RapidShock
Lead sponsor
Zoll Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct04014842
Content hash
a5babd5bc1d938746eb8e8e58360c39497c9a5b387e7c91af2771a61836edd11